ABclonal Biotechnology Overview
- Year Founded
-
2011
- Status
-
Private
- Employees
-
193
- Latest Deal Type
-
2ndary - Private
- Investors
-
27
ABclonal Biotechnology General Information
Description
Manufacturer of life science reagents and diagnostic materials intended for the research and pharmaceutical industries. The company's platform offers recombinant antibodies, molecular enzymes and genomic library preparation kits, providing researchers and diagnostic enterprises with specialized tools and bioinformatics support to improve the discovery of biomarkers and genetic disease treatments.
Contact Information
Website
www.abclonal.com.cnCorporate Office
- Number 9, Gaokeyuan Third Road, Bio-Park Third Road
- East Lake High-tech Development Zone, Wuhan Precision Medicine Industry Base
- Wuhan, Hubei
- China
Corporate Office
- Number 9, Gaokeyuan Third Road, Bio-Park Third Road
- East Lake High-tech Development Zone, Wuhan Precision Medicine Industry Base
- Wuhan, Hubei
- China
ABclonal Biotechnology Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Secondary Transaction - Private | 16-May-2025 | Completed | Generating Revenue | |||
| 9. Later Stage VC (Series D) | 08-Dec-2021 | Completed | Generating Revenue | |||
| 8. Later Stage VC (Series C) | 30-Nov-2020 | Completed | Generating Revenue | |||
| 7. Later Stage VC | 28-Aug-2020 | Completed | Generating Revenue | |||
| 6. Secondary Transaction - Private | 14-Aug-2019 | Completed | Generating Revenue | |||
| 5. Later Stage VC | 15-Jan-2019 | Completed | Generating Revenue | |||
| 4. Later Stage VC | 09-Mar-2018 | Completed | Generating Revenue | |||
| 3. Secondary Transaction - Private | 29-Sep-2017 | Completed | Generating Revenue | |||
| 2. Later Stage VC (Series B) | 09-Jan-2017 | Completed | Generating Revenue | |||
| 1. Early Stage VC (Series A) | 14-Jun-2016 | Completed | Generating Revenue |
ABclonal Biotechnology Comparisons
Industry
Financing
Details
ABclonal Biotechnology Competitors (12)
One of ABclonal Biotechnology’s 12 competitors is GenScript, a Formerly VC-backed company based in Nanjing, China.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| GenScript | Formerly VC-backed | Nanjing, China | ||||
| AnaSpec | Corporate Backed or Acquired | Fremont, CA | ||||
| BPS Bioscience | Corporation | San Diego, CA | ||||
| Creative Peptides | Corporation | New York, NY | ||||
| Mapp Biopharmaceutical | Angel-Backed | San Diego, CA |
ABclonal Biotechnology Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
ABclonal Biotechnology Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
ABclonal Biotechnology Investors (27)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Beijing Zhiming Haojin Investment Management | Growth/Expansion | Minority | ||
| CITIC Securities | Investment Bank | Minority | ||
| Citic Securities Investment | Investment Bank | Minority | ||
| CMB International Capital | Asset Manager | Minority | ||
| Loyal Valley Capital | Growth/Expansion | Minority |
ABclonal Biotechnology Investments & Acquisitions (5)
ABclonal Biotechnology’s most recent deal was a Later Stage VC with Hubei Xinzongke. The deal was made on 18-Sep-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Hubei Xinzongke | 18-Sep-2024 | Later Stage VC | Diagnostic Equipment | ||
| Hubei Xinzongke | 14-Apr-2021 | Later Stage VC | Diagnostic Equipment | ||
| Yurogen Biosystems | 05-Mar-2021 | Merger/Acquisition | Biotechnology | ||
| Monad Biology | 08-Feb-2021 | Early Stage VC | Other Commercial Products | ||
| Polariton Life | 01-Jan-2021 | Corporate | Diagnostic Equipment |
ABclonal Biotechnology Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Yurogen Biosystems | Worcester, MA | 2015 |
ABclonal Biotechnology FAQs
-
When was ABclonal Biotechnology founded?
ABclonal Biotechnology was founded in 2011.
-
Where is ABclonal Biotechnology headquartered?
ABclonal Biotechnology is headquartered in Wuhan, China.
-
What is the size of ABclonal Biotechnology?
ABclonal Biotechnology has 193 total employees.
-
What industry is ABclonal Biotechnology in?
ABclonal Biotechnology’s primary industry is Biotechnology.
-
Is ABclonal Biotechnology a private or public company?
ABclonal Biotechnology is a Private company.
-
What is ABclonal Biotechnology’s current revenue?
The current revenue for ABclonal Biotechnology is .
-
How much funding has ABclonal Biotechnology raised over time?
ABclonal Biotechnology has raised $278M.
-
Who are ABclonal Biotechnology’s investors?
Beijing Zhiming Haojin Investment Management, CITIC Securities, Citic Securities Investment, CMB International Capital, and Loyal Valley Capital are 5 of 27 investors who have invested in ABclonal Biotechnology.
-
Who are ABclonal Biotechnology’s competitors?
GenScript, AnaSpec, BPS Bioscience, Creative Peptides, and Mapp Biopharmaceutical are some of the 12 competitors of ABclonal Biotechnology.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
